South Korea’s drug safety agency said Friday it has approved pharmaceutical giant Celltrion Inc.’s COVID-19 treatment candidate on several conditions.…
Trending
- ABU VC charges PG students on responsible AI use
- NEMA urges safety amid Anambra floods
- Nonye urges residents to relocate amid floods
- Moniepoint urges media to deepen policy coverage
- SWOFON urges data-driven policies for women farmers
- Contraception investment yields big health and cost savings
- CBN rate cut may spur growth, trigger FX pressure — analysts
- CBN to deploy tools against election-driven liquidity surge — Cardoso
